Tirzepatide

(1 customer review)

$155.69$280.69

Buy More at Discounted Price
Quantity Discount Discounted price
3 - 4 3% $151.02
5 - 9 6% $146.35
10 + 8% $143.23

Availability: This product ships in 3-5 working days.

This product is Eligible for Free Shipping

Each peptide vial comes with Free Mixing Kit, which include Free Bacteriostatic Water + Syringes

SKU: N/A Categories: , ,

Description

Tirzepatide Peptide Vials

Tirzepatide
CAS Number 2023788-19-2
Molar Mass 4813.45 g·mol−1
Chemical Formula C225H348N48O68
IUPAC Name 20-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid

Brief Introduction

Tirzepatide, a novel research compound, is prominently featured in scientific investigations exploring its potential applications. It is crucial to note that Tirzepatide is strictly intended for research purposes, and any mention of human consumption is inappropriate.

Key Characteristics

Distinguished by its unique pharmacological profile, Tirzepatide stands out for its properties related to metabolic regulation. Researchers are actively examining its interactions within biological systems to unravel its full spectrum of effects.

Research Applications

Tirzepatide finds application in a variety of research studies, particularly focusing on cardiovascular health, muscle growth and repair, and wound healing. Its versatile characteristics make it a subject of interest in elucidating mechanisms that may have implications for therapeutic development.

Research Benefits

Cardiovascular Health

Studies have suggested a potential link between Tirzepatide and cardiovascular health. Research explores its impact on factors such as blood pressure and lipid profiles, indicating a promising avenue for further investigation into cardiovascular-related conditions.

Muscle Growth and Repair

Tirzepatide has garnered attention in the realm of muscle biology. Preliminary research indicates its potential role in influencing muscle growth and repair processes, with implications for conditions related to muscle wasting.

Wound Healing

Exploratory studies are underway to understand Tirzepatide’s impact on wound healing mechanisms. Initial findings suggest a possible association with accelerated wound repair processes, opening avenues for research in regenerative medicine.

Summary

In summary, Tirzepatide, as a research compound, exhibits potential benefits in cardiovascular health, muscle growth and repair, and wound healing. Researchers are actively engaged in uncovering the underlying mechanisms that may contribute to therapeutic advancements. It is essential to reiterate that Tirzepatide is exclusively intended for research purposes and should not be considered for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

  1. Ryan DH, Deanfield JE, Jacob S. Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes. Cardiovasc Endocrinol Metab. 2023 Feb 7;12(1):e0279. doi: 10.1097/XCE.0000000000000279. PMID: 36777095; PMCID: PMC9911203. [Read More].
  2. Wang R, Sun Q, Wu X, Zhang Y, Xing X, Lin K, Feng Y, Wang M, Wang Y, Wang R. Hypoxia as a Double-Edged Sword to Combat Obesity and Comorbidities. Cells. 2022 Nov 23;11(23):3735. doi: 10.3390/cells11233735. PMID: 36496995; PMCID: PMC9736735. [Read More].
  3. Neuropathy May Be an Independent Risk Factor for Amputation After Lower Extremity Burn in Adults With Diabetes. Soman Sen; Alura Barsun; Kathleen Romanowski; Tina Palmieri; David Greenhalgh. Corresponding author: Soman Sen, [email protected]. Clin Diabetes 2019;37(4):352–356. [Read More].

Additional information

Strength

5mg, 10mg

Form

Vial + Bacteriostatic Water

COA

1 review for Tirzepatide

  1. Greydon

    Fantastic product and excellent service

    Greydon
Add a review

Your email address will not be published. Required fields are marked *